VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1824458
Sex: F
Age:
State: MS

Vax Date: 05/06/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Swollen lymph nodes on right underarm; This is a spontaneous report from a contactable health care professional, the patient. A 22-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration on the right arm on 06May2021 at 11:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8B1) via an unspecified route of administration in the right arm on 14Apr2021 at 11:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 20:00, the patient experienced swollen lymph nodes on right underarm, 1 day after vaccine. The event did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes on right underarm was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824459
Sex: F
Age:
State: CA

Vax Date: 04/24/2021
Onset Date: 04/26/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: This is a spontaneous report from a non-contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERS235) via an unspecified route of administration on 24Apr2021 at 13:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included losartan (MANUFACTURER UNKNOWN) for an unknown indication from unknown date and unknown if ongoing. The patient did not receive other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 16:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 26Apr2021 at 00:00, the patient experienced terrible head to toe body aches, swollen hands and joints, body aches to where patient felt like she was poisoned; jaw aches, muscles aching to where patient had to be in bed and could not walk or function without pain. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events terrible head to toe body aches, swollen hands and joints, body aches to where patient felt like she was poisoned, jaw aches, muscles aching to where patient had to be in bed and could not walk or function without pain was resolved with sequelae on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: LOSARTAN

Current Illness:

ID: 1824460
Sex: M
Age:
State: IL

Vax Date: 04/02/2021
Onset Date: 04/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Tinnitus high frequency in background constant; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the left arm on 02Apr2021 at 18:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid, low platelets and liver fibrosis. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and cetirizine hydrochloride (ZYRTEC); all for unknown indications from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took dicloxacillin (MANUFACTURER UNKNOWN) on an unknown date and experienced drug allergy. On 06Apr2021 at 05:00, the patient experienced tinnitus high frequency in background which was constant. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus high frequency in background which was constant was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; ALLEGRA; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1824461
Sex: F
Age:
State: NE

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Hives on underside of left arm; Painful, burning and stinging; Still raised rash with same symptoms; Painful, burning and stinging; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 04May2021 at 12:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included (Facility name) chronic muscle pain, hip and knee. Pain resulting from Jan2020 school bus rear ended automobile in which she was passenger. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 13Apr2021 at 11:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient previously also received cefalexin (KEFLEX), vancomycin (MANUFACTURER UNKNOWN), clindamycin hydrochloride (CLEOCIN), desloratadine (LORETA), for unknown indication on an unknown date and experienced drug allergy. On 04May2021 at 17:00, Tuesday evening, the patient experienced hives on underside of left arm, painful, burning and stinging, still raised rash with same symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the event hives on underside of left arm, painful, burning and stinging, still raised rash was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824462
Sex: F
Age:
State:

Vax Date: 05/05/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Swelling and soreness of lymph nodes in left armpit; Swelling and soreness of lymph nodes in left armpit; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05May2021 at 14:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 14:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. On 06May2021 at 12:00, the patient experienced swelling in left armpit and soreness of lymph nodes in left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling in left armpit and soreness of lymph nodes in left armpit was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824463
Sex: F
Age:
State:

Vax Date: 04/30/2021
Onset Date: 05/03/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Cramping of uterus constantly; Swollen and sore breasts; Sore breasts; Water retention; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Apr2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient also received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 03May2021, the patient experienced cramping of uterus constantly, swollen and sore breasts and water retention. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events cramping of uterus constantly, swollen and sore breasts and water retention was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824464
Sex: F
Age:
State: AL

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Fever; Muscle Pain; Chills; Diarrhea; Heart Palpitations; Weakness; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 at 15:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included dysautonomia, A-flutter, depression, anorexia nervosa, gastroesophageal reflux disease (GERD), hypothyroidism and known allergies to shellfish, latex and adhesive. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 15:45 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 07May2021, the patient experienced fever, muscle pain, chills, diarrhea, heart palpitations and weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, muscle pain, chills, diarrhea, heart palpitations and weakness was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824465
Sex: F
Age:
State: FL

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Diarrhea; Bloated belly and gas pains, after 5 days still have bloating; Bloated belly and gas pains, after 5 days still have bloating; This is a spontaneous report from a contactable other healthcare professional, the patient. A non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 01May2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included acid reflux. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included paracetamol (TYLENOL) for an unknown indication from an unknown date and unknown if ongoing. On 01May2021 at 14:30, the patient experienced diarrhea, bloated belly and gas pains, after 5 days still had bloating (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events diarrhea, bloated belly and gas pains, after five days still had bloating was not recovered at this time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL

Current Illness:

ID: 1824466
Sex: F
Age:
State: MI

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210506; Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Extreme fatigue; Ongoing chills; This is a spontaneous report from a contactable physician. A 54-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an intramuscular route of administration in the left arm on 12Apr2021 at 10:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included nicotine dependence and anxiety. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included fluoxetine hydrochloride (PROZAC), alprazolam (XANAX) and paracetamol (TYLENOL); all for unknown indication from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an intramuscular route of administration in the left arm on 22Mar2021 at 10:00 as a single dose for COVID-19 immunisation and received sulfamethoxazole/trimethoprim (BACTRIM) and sertraline hydrochloride (ZOLOFT); both for unknown indication on unknown date and experienced drug allergy. On 13Apr2021, the patient experienced extreme fatigue and ongoing chills. On 06May2021, the patient underwent Nasal swab and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with azithromycin (Z-PAK). Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events extreme fatigue and ongoing chills was resolved with sequelae on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: PROZAC; XANAX; TYLENOL

Current Illness:

ID: 1824467
Sex: F
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Migraines everyday for a full week after; day after felt like all bones were broken, extremely painful to move; day after felt like all bones were broken, extremely painful to move; This is a spontaneous report from a non-contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 16Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome (PCOS), depression and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 26Mar2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021, the patient experienced migraines every day for a full week after, day after felt like all bones were broken and extremely painful to move. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraines every day for a full week was resolved on an unknown date in Apr2021 and of the events felt like all bones were broken and extremely painful to move was resolved on an unknow date in 2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824468
Sex: M
Age:
State: OR

Vax Date: 05/04/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Lump the size of a Lime under the right armpit.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the right arm on 04May2021 at 09:15 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medicines within two weeks prior to the vaccination. On 05May2021 at 20:00, the patient noticed a lump, the size of a lime under the right armpit. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event lump, the size of a lime under the right armpit was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824469
Sex: M
Age:
State: CA

Vax Date: 05/05/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Woke up at 1:30am with a bout of Rigors. Chills shook entire body uncontrollably for about half an hour or 45 minutes; Unexpected shaking and chills almost made mefall over a few times; Bit my tongue very hard due to shaking of jaw; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERG735) via an unspecified route of administration in the left arm on 05May2021 at 10:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient had no known health conditions or illness. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medications or supplements within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWD167) via an unspecified route of administration in the left arm on 14Apr2021 at 11:00 as a single dose for COVID-19 immunisation. On 06May2021 at 01:30, the patient woke up with a bout of rigors. Chills shook entire body uncontrollably for about half an hour or 45 minutes. His housemate brought him water and after drinking a lot of water and time, the shakes slowed down and eventually stopped. When attempted to go to the bathroom unexpected shaking and chills almost made him fall over a few times. He bit his tongue very hard due to shaking of jaw. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event bout of rigors, chills shook entire body uncontrollably for about half an hour or 45 minutes, unexpected shaking and included drinking lot of water. Therapeutic measures were not taken as a result of the vent bit tongue very hard. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events bout of rigors, chills shook entire body uncontrollably for about half an hour or 45 minutes, unexpected shaking and chills almost made him fall over a few times and bit his tongue very hard due to shaking of jaw was resolved on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824470
Sex: F
Age:
State:

Vax Date: 04/12/2021
Onset Date: 04/14/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Diarrhea a few days following injection; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis and migraines. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included golimumab (SIMPONI), erenumab (AIMOVIG) and thyroid (as reported) (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. On 14Apr2021, the patient experienced diarrhea a few days following injection x 4 weeks. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with unspecified supplements antidiarrheal medications. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event diarrhea a few days following injection was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: SIMPONI; AIMOVIG

Current Illness:

ID: 1824471
Sex: F
Age:
State: WI

Vax Date: 04/14/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Abnormally heavy menstrual bleeding after second shot; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 14Apr2021 at 17:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within four weeks prior to the vaccination. The patient previously received escitalopram oxalate (LEXAPRO) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP6955) via an unspecified route of administration in the right arm on 17Mar2021 at 17:15 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. On 07May2021, after the second shot, the patient experienced abnormally heavy menstrual bleeding. The event did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event abnormally heavy menstrual bleeding was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824472
Sex: F
Age:
State: PA

Vax Date: 05/08/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Fever; Nauseous; Terrible migraine; Fatigue; Chills; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 08May2021 at 08:45 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included herpes simplex virus (HSV2), asthma. The patient was allergic to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included Goli ACV (MANUFACTURER UNKNOWN), aciclovir (MANUFACTURER UNKNOWN), paracetamol (TYLENOL) and ibuporfen (ADVIL); all from an unknown date for an unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in right arm on 11Apr2021 (at the age of 55-years-old) at 08:45 as a single dose for COVID-19 immunisation. On 08May2021 at 20:00, the patient experienced fever, nauseous, terrible migraine, fatigue and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events fever, nauseous, terrible migraine, fatigue and chills. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, nauseous, terrible migraine, fatigue and chills were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ACYCLOVIR [ACICLOVIR]; TYLENOL; ADVIL [IBUPROFEN]; HERBAL NOS;VITAMINS NOS

Current Illness:

ID: 1824473
Sex: F
Age:
State: FL

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Breast nipple soreness/tenderness; Mild local vaccine injection site tenderness; Severe abdominal cramping followed by urgent bowel evacuation 3 hours post vaccine injection (symptoms were similar to those experienced for colonoscopy bowel prep); Severe abdominal cramping followed by urgent bowel evacuation 3 hours post vaccine injection (symptoms were similar to those experienced for colonoscopy bowel prep); This is a spontaneous report from a contactable nurse, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the right arm on 24Mar2021 at 15:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included mitral valve prolapse and occasional mild hypertension. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included olmesartan medoxomil (MANUFACTURER UNKNOWN) and nature's bounty immune 24 hour; both taken for unknown indications from an unknown date and unknown if ongoing. On 24Mar2021 at 18:00, the patient experienced severe abdominal cramping followed by urgent bowel evacuation 3 hours post vaccine injection (symptoms were similar to those experienced for colonoscopy bowel preparation). On 24Apr2021, the patient also experienced breast nipple soreness/tenderness for about 3-4 days plus mild local vaccine injection site tenderness, similar to previous vaccine injections. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event breast nipple soreness/tenderness was resolved on an unknown date in Apr2021 while the events mild local vaccine injection site tenderness, severe abdominal cramping followed by urgent bowel evacuation 3 hours post vaccine injection (symptoms were similar to those experienced for colonoscopy bowel prep) was resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: OLMESARTAN MEDOXOMIL

Current Illness:

ID: 1824474
Sex: F
Age:
State: NY

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Extreme gas, gas pains and bloating for 12 hours; Extreme gas, gas pains and bloating for 12 hours; Body aches and extreme tired for 48 hours; Body aches and extreme tired for 48 hours; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 07May2021 at 11:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included fish oil (OMEGA 3), pre/probiotic (MANUFACTURER UNKNOWN) and unspecified multivitamin (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 15:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient previously received oseltamivir phosphate (TAMIFLU) and experienced drug allergy. On 07May2021 at 16:00, the patient experienced extreme gas, gas pains and bloating for 12 hours and body aches and extreme tired for 48 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with paracetamol (TYLENOL) and bismuth subsalicylate (PEPTO BISMOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme gas, gas pains and bloating for 12 hours was resolved on 08May2021 at 04:00 while that off body aches and extreme tired for 48 hours was resolved on 09May2021 at 16:00. No follow-up attempts are needed. No further information is expected.

Other Meds: OMEGA 3 [FISH OIL]

Current Illness:

ID: 1824475
Sex: F
Age:
State: MI

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Extreme pain lymph node; Golf ball size in armpit radiating pain down inside of elbow lymph node in breast; Dollar bill size red rash swollen around the injection site; Dollar bill size red rash swollen around the injection site; Swollen around injection site; Radiating pain down inside of elbow lymph node in breast dollar bill size; This is a spontaneous report from a contactable healthcare professional, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 07May2021 at 14:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included focal seizures, anxiety and biliary colic. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included lacosamide (VIMPAT), sertraline hydrochloride (ZOLOFT), ursodeoxycholic acid (URSODIOL), pantoprazole sodium sesquihydrate (PROTONIX), estradiol (MANUFACTURER UNKNOWN) and fluticasone propionate (SINO); all for unknown indication from unknown date and unknown if ongoing. The patient previously took acetylsalicylic acid (ASPIRIN), erythromycin (MANUFACTURER UNKNOWN), hydroxychloroquine phosphate (PLAQUENIL) and meclofenamate sodium (MECLOMEN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 09Apr2021 at 14:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021 at 06:45, the patient experienced extreme pain in lymph node that was golf ball size in armpit, radiating pain down inside of elbow, lymph node in breast, dollar bill size and a red rash swollen around injection site. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme pain in lymph node that was golf ball size in armpit, radiating pain down inside of elbow, lymph node in breast, dollar bill size red rash swollen around injection site was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VIMPAT; ZOLOFT; URSODIOL; PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]; ESTRADIOL; SINO

Current Illness:

ID: 1824476
Sex: F
Age:
State: WA

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Tinnitus started since first dose on 9 April 2021; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 09Apr2021 (at the age of 36-years-old) and also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Apr2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient had no known allergies. Concomitant medications included ertugliflozin pidolate (STEGLATRO), metformin (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), enalapril (MANUFACTURER UNKNOWN) and glibenclamide (GLYBURIDE); all for unknown indications from unknown dates and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced tinnitus which started since the first dose. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus which started since the first dose was not resolved at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: STEGLATRO; METFORMIN; ATORVASTATIN; ENALAPRIL; GLYBURIDE

Current Illness:

ID: 1824477
Sex: F
Age:
State: PA

Vax Date: 05/06/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Shivering; fever; nausea; headache; tiredness; chest pain; tingling in fingers; swelling in hands and feet; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 06May2021 at 18:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously took sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 15Apr2021 at 18:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. On 07May2021 at 07:00, the patient experienced shivering, fever, nausea, headache, tiredness, chest pain, tingling in fingers, swelling in hands and feet. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shivering, fever, nausea, headache, tiredness, chest pain, tingling in fingers, swelling in hands and feet was recovered on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824478
Sex: F
Age:
State: AL

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Constant, sore armpit pain; Pain temporarily radiates; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Mar2021 at 13:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 13Apr2021 at 14:00, the patient experienced constant, sore armpit pain which started on the second day, after her second dose. There was no noticeable swelling. Pain temporarily radiated randomly, 4 weeks later bit did not linger. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events, sore armpit pain and pain temporarily radiated was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824479
Sex: F
Age:
State: CA

Vax Date: 02/19/2021
Onset Date: 02/21/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Irregular menstrual cycles; Irregular menstrual cycles, as long as 50 days apart; This is a spontaneous report from a contactable nurse, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL8982) via an unspecified route of administration in the left arm on 19Feb2021 at 08:15 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa drugs and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3248) via an unspecified route of administration in the right arm on 25Jan2021 at 09:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 21Feb2021 at 00:00, the patient experienced irregular menstrual cycles, as long as 50 days apart. This began the first cycle after the vaccine and maintained since. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event irregular menstrual cycles, as long as 50 days apart were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824480
Sex: F
Age:
State: CA

Vax Date: 03/24/2021
Onset Date: 04/30/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Increased PMS symptoms, for one full week before period started; Spotting; Cramping; Dizziness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 24Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient medical history reported was not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included IBUPROFEN and SONATA, both for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on an unknown date in Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. On 30Apr2021, the patient experienced increased premenstrual syndrome (PMS) symptoms, for one full week before period started, including spotting, cramping, dizziness, fatigue. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were not taken as a result of the event. The clinical outcome of the event increased premenstrual syndrome (PMS) symptoms, for one full week before period started, including spotting, cramping, dizziness, and fatigue was recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN; SONATA

Current Illness:

ID: 1824481
Sex: F
Age:
State: TN

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Fever; Chills; Muscle aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 07May2021 at 09:30 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa drugs since an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the arm left on 05Apr2021 at 12:15 (at the age of 30-years-old), as a single dose for COVID-19 immunisation. On 07May2021 at 21:00, the patient experienced fever, chills and muscle aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, muscle aches, and fatigue was resolved on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824482
Sex: F
Age:
State: FL

Vax Date: 04/16/2021
Onset Date: 04/17/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210417; Test Name: Body temperature; Result Unstructured Data: Test Result:fever up to 101.5; Comments: Time: 02:00

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Chills and fever up to 101.5 for two days; Chills and fever up to 101.5 for two days; Swollen armpit/lymph nodes in left arm for several days; Digestive upset for 1 day; Head pressure ache when bending over for a few days.; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the arm left on 16Apr2021 at 15:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported and the patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included calcium (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN); all for unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 26Mar2021 at 15:15 as a single dose for COVID-19 immunisation. On 17Apr2021 at 02:00, the patient experienced chills and fever up to 101.5 for two days, swollen armpit/lymph nodes in left arm for several days, digestive upset for 1 day and head pressure ache when bending over for a few days. On the 17Apr2021, the patient underwent body temperature test and the result was found to be fever up to 101.5 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events digestive upset for 1 day was resolved on an 18Apr2021; and chills and fever up to 101.5 for two days was resolved on an 19Apr2021 whereas swollen armpit/lymph nodes in left arm for several days and head pressure ache when bending over for a few days were resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: CALCIUM; IBUPROFEN

Current Illness:

ID: 1824483
Sex: F
Age:
State: AR

Vax Date: 03/17/2021
Onset Date: 03/27/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Severe vertigo; Dizziness/Lightheadedness; Motion sickness; Blurred vision; Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 17Mar2021 at 14:00 (at the age of 63-year-old), as a single dose for COVID-19 immunisation. Medical history includes history of inflammatory breast cancer, seasonal allergies and sensitivity to chemicals and fragrances. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included levothyroxine sodium (EUTHYROX) 75mcg and colecalciferol 5000 IU (VITAMIN D3); both for an unknown indication from an unknown date and unknown if ongoing. On 27Mar2021 at 07:00, 10 days after vaccination, the patient experienced severe vertigo which had not resolved since then. Vertigo was not as severe every day as it was at onset. It alternated with periods of dizziness and light-headedness and motion sickness along with blurred vision and tinnitus. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the vertigo, dizziness, light-headedness, motion sickness, blurred vision and tinnitus which included treatment with physical therapy - Epley maneuver. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe vertigo, periods of dizziness and lightheadedness and motion sickness along with blurred vision and tinnitus was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: EUTHYROX; VITAMIN D3

Current Illness:

ID: 1824484
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fever; shaking chills; Headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. On an unknown date, the patient experienced fever, shaking chills, headache, and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, shaking chills, headache, and fatigue was resolved on an unknown date. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824485
Sex: F
Age:
State: NV

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210507; Test Name: Vital signs measurement; Result Unstructured Data: Test Result:UNKNOWN RESULTS

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Bad taste in her throat; This is a spontaneous report from a contactable nurse. A non-pregnant adult female patient of unspecified age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the right arm on 07May2021 at 12:00 as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. It was unknown if the patient had known allergies. It was unknown if the patient received concomitant medications within two weeks of vaccination. It was unknown if the patient received other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 07May2021 at 12:00, the patient came to vaccination drive through clinic for her second Pfizer COVID-19 vaccination. Lot number, from the reporters recollection might have been EW0710, but the reporter could not recall with certainty. Within 10 minutes of receiving the vaccine, the patient reported of a bad taste in her throat. There was no tongue swelling evident and no problems breathing. The onsite paramedics were summoned and arrived within a few minutes. They took vital signs, the results of which were unknown. The patient was informed by paramedic that this adverse event was known to occur but was not very common. The patient required no further intervention. At the time the patient left the site, at least 30 minutes had elapsed and she had completely recovered from the bad taste in her throat. The event did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event bad taste in throat was resolved on 07May2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824486
Sex: F
Age:
State: MS

Vax Date: 05/08/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Itching; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08May2021 at 12:45 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and high blood pressure. The patient had known allergies to shellfish, sulphur and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included metformin hydrochloride/ sitagliptin phosphate monohydrate (JANUMET); olmesartan (MANUFACTURER UNKNOWN); hydrochlorothiazide (MANUFACTURER UNKNOWN) and loratadine (CLARITIN); all for unknown indications, from unknown dates and unknown if ongoing. On 08May2021 at 13:00, the patient experienced itching. The event did not result in a visit to the doctors or other healthcare professional office/clinic, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event itching was recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: JANUMET; OLMESARTAN; HCTZ; CLARITIN [LORATADINE]

Current Illness:

ID: 1824487
Sex: F
Age:
State: PA

Vax Date: 05/06/2021
Onset Date: 05/06/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210506; Test Name: Body temperature; Result Unstructured Data: Test Result:100 Units:[degF]; Comments: Fever (100F)

Allergies:

Symptom List: Nausea

Symptoms: Arm injection site pain; Chills; Fever (100F); Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 06May2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included olmesartan medoxomil (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. On 06May2021, the patient experienced arm injection site pain, chills, fever (100F) and fatigue. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 06May2021, the patient underwent body temperature test and the result was 100 Fahrenheit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events arm injection site pain, chills, fever (100F) and fatigue was resolved on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds: OLMESARTAN MEDOXOMIL

Current Illness:

ID: 1824488
Sex: F
Age:
State: VA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Hives on the chest; Swollen and sore left armpit; Swollen and sore left armpit; Right butt cheek was sore; Chills; Headache/the next day headache/ a severe and sudden headache; Soreness in arm; Swelling and pain in the inner labia; swelling and pain in the inner labia; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 05May2021 at 12:45 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included covid-19, and mild seasonal allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient received hpv vaccine (MANUFACTURER UNKNOWN) on 21Apr2021 within four weeks prior to the vaccination. On 05May2021 at 22:00 the patient started feeling a headache, soreness in arm and swelling and pain in the inner labia in the evening, the next day(06May2021), right butt cheek was sore and swollen, headache and chills. On 07May2021, she developed a severe and sudden headache, hives on the chest, soreness and pain in the inner labia and swollen and sore left armpit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, soreness in arm and swelling and pain in the inner labia, right butt cheek was sore and swollen, chills, severe and sudden headache, hives on the chest and swollen and sore left armpit were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824489
Sex: M
Age:
State: IL

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Severe left shoulder joint pain; Severe left shoulder joint pain and arm pain in that area; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 24Apr2021 at 13:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included degenerative disc disease and herniated discs. The patient was allergic to penicillin and bee stings. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included celecoxib (CELEBREX), atorvastatin calcium (LIPITOR), hydrocodone bitartrate, paracetamol (NORCO), morphine sulfate (MORPHINE SULF) and cyclobenzaprine hydrochloride (FLEXERIL); all taken for an unspecified indication from an unknown date and unknown if ongoing. On 25Apr2021 at 00:00, the patient experienced severe left shoulder joint pain and arm pain in that area. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether any therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe left shoulder joint pain and arm pain in that area was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: CELEBREX; LIPITOR; NORCO; MORPHINE SULF; FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]

Current Illness:

ID: 1824490
Sex: F
Age:
State: PA

Vax Date: 05/01/2021
Onset Date: 05/10/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: I have two rashes on my left arm; Red rash on left arm specifically located in the left medial vein /several red rashes almost a pin point looking red rashes all over my chest and red rashes on left leg near my left knee; Severe headache for the last two days; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 01May2021 at 14:30 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 10Apr2021 at 14:30 (at the age of 33-years-old), as a single dose for COVID-19 immunisation. On 10May2021 at 08:00, the patient noticed a red rash on left arm specifically located in the left medial vein. It was approximately a dime size. The patient had two rashes on left arm and had several red rashes almost a pin point looking red rashes all over chest and red rashes on left leg near left knee. The patient was not taking any medications and it was first time to have red rashes like this, it was not itchy however. The patient had a severe headache for the last two days. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red rash on left arm specifically located in the left medial vein, two rashes on left arm, several red rashes almost a pin point looking red rashes all over chest and red rashes on left leg near left knee, a severe headache was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824491
Sex: F
Age:
State: GA

Vax Date: 05/06/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies: Peanut allergy

Symptom List: Tremor

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# unknown), at the age of 32, via an unspecified route of administration, on May 6, 2021, at 14:15, single dose, for COVID-19 immunisation. Medical history not reported. The patient allergic to peanuts. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included postnatal multivitamin since an unknown date for an unknown indication and unknown if ongoing. On May 7, 2021, patient experienced petechiae localized on abdomen (about one inch by two inches). The events did not result in doctor or other healthcare professional office, clinic visit/emergency room, department or urgent care. Therapeutic measures not taken as a result of the events petechiae localized on abdomen (about one inch by two inches). Since the vaccination, patient has not tested for COVID-19. The outcome of petechiae localized on abdomen: not resolved (at the time of report). No follow-up attempts required. Information about batch/lot number cannot be obtained. No further information expected.

Other Meds:

Current Illness:

ID: 1824492
Sex: F
Age:
State: NY

Vax Date: 04/10/2021
Onset Date: 04/13/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Ringing/humming in the right ear; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 10Apr2021 at 16:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified multivitamin from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 13Apr2021, the patient experienced ringing/humming in the right ear that developed 3 days post the vaccine. It has not improved with time. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ringing/humming in the right ear was not resolved at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 01May2021 at 13:00 as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824493
Sex: F
Age:
State: MN

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Swollen lymph node in left armpit; Swollen lymph node in left armpit, tender to touch and movement; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 07May2021 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included mental health conditions. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ethinylestradiol, etonogestrel (NUVARING), topiramate (MANUFACTURER UNKNOWN) and duloxetine (MANUFACTURER UNKNOWN) all were taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. On 08May2021, the patient experienced swollen lymph node in left armpit, tender to touch and movement. Therapeutic measures were taken as a result of swollen lymph node in left armpit, tender to touch and movement and included treatment with ibuprofen from an unknown date to an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen lymph node in left armpit, tender to touch and movement was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NUVARING; TOPIRAMATE; DULOXETINE

Current Illness:

ID: 1824494
Sex: F
Age:
State: NJ

Vax Date: 05/07/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210507; Test Name: Body temperature; Result Unstructured Data: Test Result:101.5; Comments: Time: 23:30, 101.5 fever

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: 101.5 fever; Nausea; Body aches; Slight headache; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 07May2021 at 10:15 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 07May2021 at 23:30, the patient experienced 101.5 fever, nausea, body aches and slight headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On 07May2021 at 23:30, the patient underwent body temperature test and the result was found to be 101.5 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events 101.5 fever, nausea, body aches and slight headache was resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824495
Sex: F
Age:
State:

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Intermittent menstrual spotting; Late period; Cramping; Large menstrual clot; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 24Apr2021 at 12:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. It was not known if the patient was pregnant. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), gabapentin (MANUFACTURER UNKNOWN) and sertraline hydrochloride (ZOLOFT); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Apr2021, the patient experienced intermittent menstrual spotting, late period, large menstrual clot and cramping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events intermittent menstrual spotting, late period, large menstrual clot and cramping was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ADDERALL; GABAPENTIN; ZOLOFT

Current Illness:

ID: 1824496
Sex: F
Age:
State: NY

Vax Date: 04/10/2021
Onset Date: 04/12/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: After 2 days Tingling throughout body.; After 2 days tingling and burning sensation throughout body; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included pituitary tumour, penicillin allergy. The patient previously received ciprofloxacin (CIPRO) for an unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cabergoline (MANUFACTURER UNKNOWN) for an unknown indication, from an unknown start date and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 12Apr2021 at 12:15, the patient experienced tingling and burning sensation throughout body after 2 days of vaccination. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling and burning sensation throughout body was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CABERGOLINE

Current Illness:

ID: 1824497
Sex: M
Age:
State:

Vax Date: 05/01/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Migraines; Nausea; Fever; Chills; Aches; This is a spontaneous report from a non-contactable consumer, the patient. A 16-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date in May2021 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07May2021, the patient experienced migraines, nausea, fever, chills and aches. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event migraines, nausea, fever, chills and aches were resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824498
Sex: F
Age:
State: NC

Vax Date: 05/05/2021
Onset Date:
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Itching; She has been breaking out on her arm, neck, and back; She found bumps on the side of her face; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported that a 55-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EW0161) via an unspecified route of administration, administered in Arm Left on 05May2021 (55-year-old at the time of vaccination) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The concomitant medications were reported as yes (not specified). Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, Lot Number: ER8733), via an unspecified route of administration, administered in Arm Left on 14Apr2021 as dose 1, single for COVID-19 immunization. On an unspecified date of 2021, the patient experienced itching, she has been breaking out on her arm, neck, and back, ear and her arm and bumps on the side of her face. The patient took the second shot last week on 05May2021, and since she has been itching. She has been breaking out on her arm, neck, and back. It was off and on. The patient would come home from work, and undress and be itching. It was weird. The patient did not have a prescribing doctor. She had no side effects with the first shot. This itching was like 50/50, but it has not improved. It was annoying the patient. It comes and goes. Today she noticed it on her arm. Today it is on the back of her ear and her arm. When the patient gets undressed it was going down her leg. There are several places on her face that started itching today. She found bumps on the side of her face. Therapeutic measures were taken as a result of itching using calamine lotion on itchy spots, and she may go get some Benadryl. Her cousin works in the lab. The outcome of the event Itching was not recovered while other events was unknown. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824499
Sex: M
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/16/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Overactive bladder. No sign of infection or debris in urine after getting evaluated by a doctor.; Pressure in bladder.; Have to get up multiple times during night to urinate.; This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 (at the age of 22-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07May2021 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 16Apr2021, the patient experienced overactive bladder. There was no sign of infection or debris in urine after getting evaluated by a doctor. The patient had to get up multiple times during night to urinate. The patient experienced pressure in bladder. Medication did not help. It was reported that many other people had also reported similar symptoms online. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with medications (unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events overactive bladder, got up multiple times during night to urinate and pressure in bladder were not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824500
Sex: F
Age:
State:

Vax Date:
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Period came earlier by 1-2 weeks after first vaccination; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 01May2021, the patient reported period came earlier by 1-2 weeks after first vaccination. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event period came earlier was resolved on an unknown date in May2021 No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824501
Sex: F
Age:
State: AZ

Vax Date: 05/04/2021
Onset Date: 05/04/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210504; Test Name: Body temperature; Result Unstructured Data: Test Result:104.2; Comments: at 20:15

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: High grade fever of 104.2; Extreme muscle aches; Migraine for 4 days straight; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 04May2021 at 17:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 14:00 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 20:15, the patient experienced high grade fever of 104.2 (unspecified units), extreme muscle aches, migraine for 4 days straight. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the events. The clinical outcome of the events high grade fever of 104.2 and extreme muscle aches was recovering at the time of this report, whereas the outcome of migraine was recovered on 08May2021, after a duration of 4 days. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1824502
Sex: F
Age:
State:

Vax Date: 05/05/2021
Onset Date: 05/07/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Friday evening body rash appeared; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05May2021 at 12:00 at the age of 41-years-old as a single dose for COVID-19 immunisation. Medical history included thyroid issues. It was unknown if the patient had any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 07May2021 at 21:00, Friday evening, the patient experienced body rash appeared. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event body rash was not resolved at the time of this report. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824503
Sex: F
Age:
State: NJ

Vax Date: 04/11/2021
Onset Date: 04/21/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Exacerbated and extensive nerve pain predominately on the left side of ''my'' body, face both arms, neck, lower back and entire length of ''my'' left leg. Present but not as significant pain on ''my'' right side; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 11Apr2021 at 16:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included myofascial pain syndrome, attention deficit hyperactivity disorder (ADHD) inattention, chronic fatigue, fibromyalgia and known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), rosuvastatin calcium (ROSUVASTIN), modafinil (MANUFACTURER UNKNOWN) and dexamfetamine (DEXTROAMPHETAMINE), all for an unknown indication on an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. On 21Apr2021, the patient experienced exacerbated and extensive nerve pain predominately on the left side of her body, face both arms, neck, lower back and entire length of her left leg. Present but not as significant pain on her right side. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of reported event. The clinical outcome of the event exacerbated and extensive nerve pain predominately on the left side of her body, face both arms, neck, lower back and entire length of her left leg. Present but not as significant pain on her right side was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTIN; METFORMIN; ROSUVASTIN; MODAFINIL; DEXTROAMPHETAMINE [DEXAMFETAMINE]

Current Illness:

ID: 1824504
Sex: F
Age:
State: GA

Vax Date: 04/12/2021
Onset Date: 04/12/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210412; Test Name: Heart rate; Result Unstructured Data: Test Result:100 BPM; Comments: elevated heart rate for 1 week over 100 BPM; Test Date: 20210420; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Rash on Left lower extremity-lasted one week; over all joint pain for several hours; Elevated heart rate for 1 week over 100 BPM; This is a spontaneous report from a contactable other healthcare professional, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 at 09:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included prenatal (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 12Apr2021 at 10:00, the patient experienced rash on left lower extremity that lasted one week, over all joint pain for several hours and elevated heart rate for 1 week over 100 beats per minutes. On the same day, the patient underwent Heart rate and the result was 100 beats per minutes. On 20Apr2021, the patient underwent Nasal swab and the result was Negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events rash on left lower extremity that lasted one week and elevated heart rate for 1 week over 100 beats per minutes was resolved on an unknown date in Apr2021 and of the event over all joint pain for several hours was resolved on 12Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824505
Sex: F
Age:
State: GA

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Muscle aches; Fever; Headache; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EV0162) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 at the age of 37-years-old as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 18Mar2021 at 10:45 at the age of 36-years-old as a single dose for COVID-19 immunisation. On 08Apr2021 at 22:00, the patient experienced muscle aches, fever, and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle aches, fever, and headache was resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1824506
Sex: F
Age:
State:

Vax Date: 04/23/2021
Onset Date: 04/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Fatigue; muscle soreness; Tightness in chest; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Apr2021 at 08:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on 02Apr2021 at 09:00 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On an unknown date in Apr2021, since second injection, the patient experienced fatigue, muscle soreness and tightness in chest. The adverse events did not result in doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, muscle soreness and tightness in chest were unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1824507
Sex: F
Age:
State:

Vax Date: 05/01/2021
Onset Date: 05/01/2021
Rec V Date: 10/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Extreme tiredness/fatigue set in six days after the shot, and lasted approximately one day. This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on an unknown date in May2021at 14:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had unspecified allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021, the patient experienced extreme tiredness/fatigue set in six days after the shot, and lasted approximately one day. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event extreme tiredness/fatigue was recovered on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am